SMMT (summittxinc.com) Bathi resik saben saham (EPS TTM)

Summit Therapeutics relies on innovations from its laboratories in the US and Europe to combat infections. The 12-month net income per share history reflects the dynamics of this process, where -1.08 captures the current value of the indicator. However, fierce competition with oncology behemoths and liquidity shortages due to costly clinical trials create serious risks to business stability.

SMMT (Summit Pharma) riwayat Bathi resik saben siji saham sajrone rolas wulan pungkasan saka 04.07.2022 nganti 12.11.2026

Summit Therapeutics plc (SMMT) - rincian metrik lan laporan keuangan

- kuotasi saiki lan rata-rata prakiraan nilai:

Bagan rega Summit Therapeutics|SMMT - Prakiraan gabungan firma investasi

- indikator valuasi pasar bisnis:

Kapitalisasi pasar Summit Therapeutics Inc.|SMMT - Nilai Wutuh Bisnis

- rincian valuasi buku bisnis:

Nilai Buku saben Saham Summit Therapeutics|SMMT - Ekuitas Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku summittxinc.com|SMMT - Gunggung Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Rasio Total Utang marang Ekuitas Summit Therapeutics|SMMT - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang modal Summit Therapeutics Inc|SMMT - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Summit Therapeutics Inc.|SMMT - Utang jangka dawa|Utang jangka cendhak perusahaan Summit Therapeutics|Likuiditas cepet summittxinc.com

- indikator pendapatan resik lan kelipatan nilai:

SMMT - Asil keuangan resik|Bathi sing dikarepake Summit Therapeutics|SMMT - Periode bali modal bisnis|Prakiraan rega marang bathi Summit Therapeutics Inc.|SMMT - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Summit Therapeutics Inc.|SMMT - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Summit Therapeutics|SMMT - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan summittxinc.com|SMMT - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Summit Therapeutics

Analisis fundamental perusahaan:SMMT - Summit Therapeutics

Net income per share (TTM) measures the actual return of a single security, excluding paper revaluations to assess the fundamental stability of the business. By analyzing the current EPS TTM level, an investor can see how strategic partnerships and developments in infectious diseases translate into financial results, separating the long-term adaptation of Summit Therapeutics (SMMT) laboratories from short-term market volatility.

Pesaing utama

MRNA - Bathi saben saham sajrone rolas wulan pungkasan|PCVX (vaxcyte.com) - Bathi saben saham sajrone 12 wulan pungkasan|TARS: Bathi resik saben saham (EPS TTM)|Bathi saben siji saham sajrone 12 wulan pungkasan CRMD (CorMedix Inc)|MCRB (Seres) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan Spero Pharma SPRO|Bathi resik saben saham (EPS TTM) SCYX|Bathi resik saben saham sajrone 12 wulan pungkasan an2therapeutics.com ANTX|PolyPid - Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajrone patang kuartal pungkasan LSB (LakeShore Biopharma Co., Ltd.)|Iterum Therapeutics, plc - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone patang kuartal pungkasan BiomX Inc. PHGE|soligenix.com (SNGX) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi resik saben siji saham sajrone rolas wulan pungkasan 60 Degrees Pharmaceuticals, Inc. (SXTP)|Bathi saben saham sajrone rolas wulan pungkasan Oragenics|Bathi saben saham sajrone 12 wulan pungkasan OPGN (OpGen Inc)